MYLAN 5280 (Diltiazem XR 180 mg)
Pill imprint MYLAN 5280 has been identified as Diltiazem hydrochloride extended-release (XR) 180 mg.
Diltiazem is used in the treatment of atrial fibrillation; supraventricular tachycardia; high blood pressure; atrial flutter; raynaud's syndrome (and more), and belongs to the drug classes calcium channel blocking agents, group IV antiarrhythmics. Risk cannot be ruled out during pregnancy. Diltiazem 180 mg is classified as a Schedule N controlled substance under the Controlled Substance Act (CSA).
- 180 mg
- Purple / Pink
- 15.00 mm
- Prescription only
Group IV antiarrhythmics
sodium lauryl sulfate
FD&C Blue No. 1
FD&C Red No. 40
D&C Red No. 28
D&C Yellow No. 10
FD&C Blue No. 2
|NDC Code||Manufacturer / Repackager|
|51079-0948||UDL Laboratories Inc|
Note: Inactive ingredients may vary.
More about diltiazem
- Diltiazem 12-hour sustained-release capsules
- Diltiazem 24-hour extended-release beads capsules
- Diltiazem 24-hour extended-release beads tablets
- Diltiazem 24-hour sustained-release beads capsules
- More (4) »
Related treatment guides
Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.
Copyright 2015 Drugs.com, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.